Grabner Bernhard, Quehenberger Peter, Schaefer Anne-Kristin, Steinlechner Barbara
Division of Cardiothoracic and Vascular Anesthesia, Medical University of Vienna, Vienna, Austria.
Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Eur J Cardiothorac Surg. 2020 Apr 1;57(4):796-798. doi: 10.1093/ejcts/ezz165.
Acquired von Willebrand syndrome is a frequently encountered complication of continuous flow ventricular assist devices, which may lead to clinically relevant bleeding in up to 30% of patients after continuous flow ventricular assist device implantation. As standard anticoagulation strategies may be detrimental, individualized treatment is called for, as described in our patient on the HeartMate III® left ventricular assist device.
获得性血管性血友病综合征是连续血流心室辅助装置常见的并发症,在连续血流心室辅助装置植入术后,高达30%的患者可能会出现具有临床意义的出血。由于标准抗凝策略可能有害,因此需要个体化治疗,正如我们这位使用HeartMate III®左心室辅助装置的患者的情况。